Yaqub S, Valberg M, Bjørnbeth BA, Angelsen JH, Brudvik KW, Eilertsen IA, Fristedt R, Fristrup CW, Gilg S, Hemmingsson O, Isaksson B, Juel IS, Knudsen AR, Larsen PN, Mortensen KE, Olsen IC, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Lothe RA, Taskén K, ASAC Study Group (2026)
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Lancet Gastroenterol Hepatol (in press)
DOI 10.1016/S2468-1253(26)00260-8, PubMed 42777749

Sveen A, Stenersen JM, Asenso TQ, Klokkerud SK, Kranjec C, Eilertsen IA, Johannessen B, Leithe E, Kryeziu K, Zucknick M, Lothe RA (2026)
Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines
Mol Biomed, 7 (1)
DOI 10.1186/s43556-026-00551-z, PubMed 42640371

Totland MZ, Rasmussen NL, Elster VCW, Arnesen KI, Bergmann DG, Bergill I, Stenersen JM, Larsen M, Moe JJ, Basing S, Sørensen V, Aasen T, Leithe E (2026)
Regulation of ubiquitination and degradation of the gap junction channel protein Connexin43 involves the concerted action of multiple members of the NEDD4 family of E3 ubiquitin ligases
Cancer Lett, 659, 218796
DOI 10.1016/j.canlet.2026.218796, PubMed 42641867